The pancreas.
Recombinant DNA technology is used to produce insulin for diabetics. This involves inserting the human insulin gene into bacteria or yeast cells, which then produce insulin that is identical to the one produced by our bodies.
bacteria itself is not the treatment. we use the bacteria to produce insulin, we do so by inserting the gene into their plasmids and trigger them to produce the insulin. the insulin is extracted and used.
The human gene that codes for insulin is inserted into bacteria to produce insulin. The gene is typically inserted into a plasmid vector, which allows the bacteria to express the human insulin gene and produce insulin. This technique is used in biotechnology to create recombinant bacteria that can produce insulin for medical use.
Bacteria can be genetically modified to produce human insulin, which can then be harvested and used as a treatment for individuals with diabetes. This process involves inserting the gene for insulin production into the bacteria's DNA, allowing them to produce insulin in large quantities.
*A+*bacteria
Bacterial cells are commonly used in biotechnology to produce insulin using exogenous DNA. The exogenous DNA encoding for human insulin is introduced into the bacterial cells, which then serve as a host to produce the insulin protein through the process of genetic engineering.
The insulin gene will be extracted from cells from an animal such as a pig, and placed into the loop of DNA in a microorganism. When the microorganism reproduces, the DNA gene will reproduce with it, and this is repeated again and again and the micro-organsms will produce insulin. Whe a sufficient amount of microorganisms have been grown, the insulin will be extracted and used in medicine
E. coli that contains the gene for human insulin is genetically engineered, transgenic, and a GMO. Bacteria have been engineered to produce chymotrypsin, make human insulin, produce enzymes that increase shelf life of bread, and to produce enzymes that improve the taste and clarity of beer.
The type of DNA technology used to cause bacteria to produce human insulin is recombinant DNA technology. In this process, the gene for human insulin is inserted into the genome of a bacterium, such as Escherichia coli (E. coli), using techniques such as restriction enzymes and ligase enzymes. Once the gene is inserted, the bacterium is then able to produce human insulin, which can be purified and used for medical purposes. This technology has revolutionized the production of insulin, making it more accessible and affordable for people with diabetes. Recombinant DNA technology has also been used to produce many other human proteins, such as growth hormone and blood clotting factors, with great success.
Well, the insulin a diabetic gets does not contain any bacteria. It is sterile. However, the insulin is made by bacteria, usually E. coli. Hope this helps! Some Stuff about the E.Coli Bacteria: • • The Bacteria E.coli used to produce insulin for those with diabetes • It's Inexpensive - compared with 1980 methods(extracting insulin from pigs etc.) • Large quantities of the modified bacteria are killed and insulin is extracted and purified. •The Bacteria E.coli used to produce insulin for those with diabetes
E. coli can be genetically engineered to produce insulin through the introduction of the gene encoding insulin. This allows the bacteria to synthesize and secrete insulin protein, which can then be harvested and used for medical purposes, such as treating diabetes.